Statistical Considerations for Premarketing Risk Assessment - 05/16/2024

Statistical Considerations for Premarketing Risk Assessment
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news